HIV and the Seroprevalence of SARS-CoV-2
View ORCID ProfileRobert L. Stout, Steven J. Rigatti
doi: https://doi.org/10.1101/2021.04.29.21256302
Robert L. Stout
Clinical Reference Laboratory, Inc. 8433 Quivira Rd Lenexa, KS 66215
PhDSteven J. Rigatti
Clinical Reference Laboratory, Inc. 8433 Quivira Rd Lenexa, KS 66215
MDArticle usage
Posted May 03, 2021.
HIV and the Seroprevalence of SARS-CoV-2
Robert L. Stout, Steven J. Rigatti
medRxiv 2021.04.29.21256302; doi: https://doi.org/10.1101/2021.04.29.21256302
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2318)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11653)
- Forensic Medicine (10)
- Gastroenterology (687)
- Genetic and Genomic Medicine (3656)
- Geriatric Medicine (344)
- Health Economics (625)
- Health Informatics (2340)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (102)
- Nephrology (394)
- Neurology (3407)
- Nursing (193)
- Nutrition (512)
- Oncology (1787)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (442)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6047)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (391)
- Toxicology (50)
- Transplantation (171)
- Urology (144)